Management of Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State.
Fayfman M, Pasquel FJ, Umpierrez GE.
Med Clin North Am. 2017 May;101(3):587-606. doi: 10.1016/j.mcna.2016.12.011.
Important Drop in Rate of Acute Diabetes Complications in People With Type 1 or Type 2 Diabetes After Initiation of Flash Glucose Monitoring in France: The RELIEF Study.
Roussel R, Riveline JP, Vicaut E, de Pouvourville G, Detournay B, Emery C, Levrat-Guillen F, Guerci B.
Diabetes Care. 2021 Jun;44(6):1368-1376. doi: 10.2337/dc20-1690. Epub 2021 Apr 20.
Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia.
Umpierrez G, Korytkowski M.
Nat Rev Endocrinol. 2016 Apr;12(4):222-32. doi: 10.1038/nrendo.2016.15. Epub 2016 Feb 19.
Hyperosmolar Hyperglycemic Syndrome.
Adeyinka A, Kondamudi NP.
2023 Aug 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
[Acute diabetic complications attended in a hospital emergency department: a descriptive analysis].
Sanz-Almazán M, Montero-Carretero T, Sánchez-Ramón S, Jorge-Bravo MT, Crespo-Soto C.
Emergencias. 2017 Jul;29(4):245-248.
A comparison of the rapid-acting insulin analogue glulisine with lispro and aspart for the pump treatment of patients with type 1 diabetes.
Bramlage P, Tittel SR, Müther S, Reinhart-Steininger B, Haberland H, Khodaverdi S, Zimny S, Ohlenschläger U, Lanzinger S, Haak T.
Acta Diabetol. 2022 Nov;59(11):1453-1460. doi: 10.1007/s00592-022-01939-3. Epub 2022 Aug 7.
Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes.
Wessels AM, Scheltens P, Barkhof F, Heine RJ.
Eur J Pharmacol. 2008 May 6;585(1):88-96. doi: 10.1016/j.ejphar.2007.11.080. Epub 2008 Mar 4.
Repurposed Analog of GLP-1 Ameliorates Hyperglycemia in Type 1 Diabetic Mice Through Pancreatic Cell Reprogramming.
Villalba A, Rodriguez-Fernandez S, Perna-Barrull D, Ampudia RM, Gomez-Muñoz L, Pujol-Autonell I, Aguilera E, Coma M, Cano-Sarabia M, Vázquez F, Verdaguer J, Vives-Pi M.
Front Endocrinol (Lausanne). 2020 May 13;11:258. doi: 10.3389/fendo.2020.00258. eCollection 2020.
The Hypoglycaemia-Hyperglycaemia Minimizer System in the Management of Type 1 Diabetes.
Levy BL, McCann TW Jr, Finan DA.
Eur Endocrinol. 2016 Mar;12(1):18-23. doi: 10.17925/EE.2016.12.01.18. Epub 2016 Mar 15.
Sustained Impact of Intermittently Scanned Continuous Glucose Monitoring on Treatment Satisfaction and Severe Hypoglycemia in Adults with Type 1 Diabetes (FUTURE): An Analysis in People with Normal and Impaired Awareness of Hypoglycemia.
Charleer S, De Block C, Bolsens N, Van Huffel L, Nobels F, Mathieu C, Gillard P.
Diabetes Technol Ther. 2023 Apr;25(4):231-241. doi: 10.1089/dia.2022.0452. Epub 2023 Feb 3.
